Please login to the form below

Not currently logged in
Email:
Password:

Amarin

This page shows the latest Amarin news and features for those working in and with pharma, biotech and healthcare.

Pfizer takeover rumour ignites Amarin shares

Pfizer takeover rumour ignites Amarin shares

Fish oil product shows great promise. Pfizer is rumoured to be on the brink of a deal to acquire small biopharma Amarin in the wake of stellar data for its purified ... The aim will be to build the pipeline and also add to revenue growth – and adding

Latest news

  • The Midas Touch The Midas Touch

    Then along comes Amarin. By investing in the isolation of a single compound from the soup that is fish-oil, they have developed a product called Vascepa. ... Well done Amarin. The practical lesson of Amarin’s Vascepa for the rest of us is hidden in

  • Amarin hits jackpot with astonishing heart benefits from fish oil product Amarin hits jackpot with astonishing heart benefits from fish oil product

    Amarin CEO John Thero. “We are delighted with these topline study results,” said John Thero, president and CEO of Amarin. ... of LDL-C control with standard of care statin therapy in studied patients,” added Craig Granowitz, MD, PhD, senior vice

  • Amarin sues FDA over off-label policy Amarin sues FDA over off-label policy

    Claims block on discussing off-label uses conflicts freedom of speech. Irish pharma company Amarin Corp is suing the FDA, claiming that a block on discussing off-label uses for drugs ... Amarin is in the process of carrying out a cardiovascular outcomes

  • Teva launches first generic of GSK's Lovaza in US Teva launches first generic of GSK's Lovaza in US

    Aside from GSK, the launch of a lower-priced Lovaza generic in the US also impacts Amarin Pharmaceuticals' Vascepa (icosapent ethyl), another fish oil-based therapy that is already on the

  • Amarin slides as FDA panel votes against fish oil therapy Amarin slides as FDA panel votes against fish oil therapy

    Advisory committee wants more data on Vascepa. Shares in Irish company Amarin Corp nosedived yesterday after a US Food and Drug Administration (FDA) advisory committee voted against approval of its fish ... Meanwhile, the cost of running REDUCE-IT is

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Teva's Mark Salyer joins Amarin Teva's Mark Salyer joins Amarin

    Takes up newly-created chief commercial officer role. Amarin has appointed Mark Salyer to the newly-created position of chief commercial officer. ... Salyer’s appointment comes at a key juncture for Amarin as it awaits next year’s publication of

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics